Disease | congestive heart failure |
Phenotype | C0024117|chronic obstructive pulmonary disease |
Sentences | 4 |
PubMedID- 22615527 | Background: tiotropium partially relieves exertional dyspnea and reduces the risk of congestive heart failure in chronic obstructive pulmonary disease (copd) patients. |
PubMedID- 24353412 | Background: congestive heart failure is underdiagnosed in patients with chronic obstructive pulmonary disease (copd). |
PubMedID- 20299349 | Mean pulmonary and wedge pressures assessed by right catheterization were 25.2 ± 10.8 and 18.4 ± 9.1 mmhg, respectively.table 2baseline demographic and clinical characteristicsn = 31age, median (iqr)71 (62–79)age > 65 years22 (71)male sex25 (81)diabetes mellitus10 (32)hypertension18 (58)chronic kidney diseasea6 (19)chronic obstructive pulmonary disease0history of congestive heart failureb11 (36)history of coronary artery disease14 (45)previous coronary artery bypass graft2 (6)atrial fibrillation8 (26)high-risk criteria for mitral valve surgery with cardiopulmonary bypassc contraindications to extracorporeal circulation12 (39) logistic euroscore > 20%7 (23) autoimmune disease5 (16) severe renal failure requiring haemodialysis4 (13) hepatic cirrhosis3 (10)data are expressed as counts and percentages if not otherwise specified. |
PubMedID- 25784798 | Impact of beta-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease. |
Page: 1